Details of the Drug Reposition

General Information of This Drug (ID: DMJY2TM)

Drug Name
Gabapentin enacarbil   DMJY2TM
Synonyms 1838262; ASP8825; Gabapentin-XP; GSK 1838262; Horizant; Regnite; Solzira; XP13512
Therapeutic Class
Neurology Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Postherpetic neuralgia DISCQ39I 1E91.5 Approved [1]
Alcohol dependence DIS4ZSCO 6C40.2 Approved [2]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Restless legs syndrome DISNWY00 7A80 Discontinued in Phase 2 [3]
------------------------------------------------------------------------------------

References

1 Gabapentin enacarbil FDA Label
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain